Results for “ ”

Entry Author Date Location
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics 04/08/20 Boston
Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests 04/08/20 Boston
Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers 04/08/20 National
Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug 04/07/20 Boston
Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13 04/07/20 Boston
GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months 04/06/20 San Francisco
Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment 04/06/20 Boston
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs 04/03/20 Boston
Flagship Adds $1.1B for New Meds, More AI, & “Health Security” 04/02/20 National
Iteos Therapeutics Adds $125M to Advance Next-Gen Immunotherapies 04/02/20 Boston
Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic 04/01/20 Boston
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
Sanofi Adds mRNA COVID-19 Vaccine Bet Through Translate Bio Alliance 03/27/20 Europe
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Oncology Needs Combo Therapies & More Data Analysis, Says Bio-Europe Spring Panel 03/26/20 Boston
Regenacy Pharma Raises $30M for Nerve Function Restoring Treatments 03/25/20 Boston
AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics 03/25/20 Europe
Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown 03/23/20 National
Keros Outlines IPO Plans Amid Markets Rocked by Coronavirus Pandemic 03/23/20 Boston
Bio Roundup: Coronavirus Diagnostics, Therapeutics, Vaccines & More 03/20/20 National
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future 03/19/20 Boston
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
Rubius Drops Rare Diseases, Turns to Cancer and Autoimmune Disorders 03/12/20 Boston
Harbour BioMed Tacks on $75M to Advance Broad Biologics Pipeline 03/12/20 Boston
Imara Dives Into Coronavirus-Churned Financial Waters With a $75M IPO 03/12/20 Boston
Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic 03/12/20 Boston
Acceleron Drops Drug for Rare Muscle Disease After Mixed Phase 2 Data 03/10/20 Boston
Kala to Take Another Shot at FDA Approval With New Dry Eye Drug Data 03/09/20 Boston
Cushing’s Disease Drug That Novartis Sold to Recordati Nabs FDA Nod 03/09/20 Europe
Page 1 of 630 next page »